GlaxoSmithKline | GSK

Stock Price
2,044.00
Daily Change
-10.00 -0.49%
Monthly
-7.13%
Yearly
38.34%
Q1 Forecast
2,019.62

Date Reference Time Actual Consensus Previous
2026-04-29 FY2026Q1 AM 0.43 0.45
2026-02-04 FY2025Q4 AM 0.26 0.24 0.23
2025-10-29 FY2025Q3 AM 0.55 0.47 0.50
2025-07-30 FY2025Q2 AM 0.47 0.43 0.43
2025-04-30 FY2025Q1 PM 0.45 0.41 0.43



Peers Price Chg Day Year Date
AbbVie 211.08 3.90 1.88% 4.12% Mar/26
Alcon AG 59.88 0.36 0.60% -29.22% Mar/26
Almirall 11.92 0.34 2.94% 18.25% Mar/26
Amgen 353.01 -0.92 -0.26% 15.45% Mar/26
argenx SE 601.80 0.60 0.10% 9.06% Mar/26
AstraZeneca 13,830.00 -232.00 -1.65% 23.53% Mar/26
Bayer 38.28 0.15 0.38% 68.84% Mar/26
Biogen 191.40 2.22 1.17% 36.39% Mar/26
Bristol-Myers Squibb 59.35 0.41 0.70% 0.76% Mar/26
Fresenius Medical Care 38.87 0.47 1.22% -14.67% Mar/26

Indexes Price Day Year Date
GB100 9961 -145.42 -1.44% 14.95% Mar/26
EU600 581 -6.65 -1.13% 6.32% Mar/26

GlaxoSmithKline traded at 2,044.00 this Thursday March 26th, decreasing 10.00 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline lost 7.13 percent. Over the last 12 months, its price rose by 38.34 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 2,019.62 by the end of this quarter and at 1,892.14 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.



News Stream
GlaxoSmithKline Stock Price Hits 6-week Low
GlaxoSmithKline shares decreased to 1945.00 GBp, the lowest since February 2026. Over the past 4 weeks, GlaxoSmithKline lost 12.09%, and in the last 12 months, it increased 28.76%.
2026-03-19
GlaxoSmithKline Stock Price Hits 4-week Low
GlaxoSmithKline shares decreased to 2107.00 GBp, the lowest since February 2026. Over the past 4 weeks, GlaxoSmithKline lost 4%, and in the last 12 months, it increased 40.62%.
2026-03-05
GlaxoSmithKline Stock Price Hits 21-1/2-year High
GlaxoSmithKline shares increased to 2221.00 GBp, the highest since July 2004. Over the past 4 weeks, GlaxoSmithKline gained 21.97%, and in the last 12 months, it increased 53.5%.
2026-02-17